KMT2A and chronic myelogenous leukemia, BCR-ABL1 positive: Overexpression of the miR-17-92 cluster has been shown to enhance proliferation in CML lines [26], BL and DLBCL lines [27], and to play a role in a mouse model of MLL-leukemia [28], by targeting the cell cycle inhibitor p21.